Cargando…

The Effects of Hydroxyurea Therapy on the Six-Minute Walk Distance in Patients with Adult Sickle Cell Anemia: An Echocardiographic Study

BACKGROUND: The impact of hydroxyurea (HU) medication as treatment of choice has not been evaluated in adult sickle cell anemia (SCA) patients in terms of the 6-min walk distance (6 MWD). AIM: The aim of the study was evaluating the effects of HU on the 6 MWD, serum brain natriuretic peptide (NT-pro...

Descripción completa

Detalles Bibliográficos
Autores principales:	Garadah, Taysir, Mandeel, Fatema, Jaradat, Ahmed, Bin Thani, Khalid
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2019
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6938284/ https://www.ncbi.nlm.nih.gov/pubmed/31920416 http://dx.doi.org/10.2147/JBM.S203828

Ejemplares similares

Hormonal and echocardiographic abnormalities in adult patients with sickle-cell anemia in Bahrain
por: Garadah, Taysir S, et al.
Publicado: (2016)

Pain frequency, severity and QT dispersion in adult patients with sickle cell anemia: correlation with inflammatory markers
por: Garadah, Taysir S, et al.
Publicado: (2016)

Thyroid Function Status and Echocardiographic Abnormalities in Patients with Beta Thalassemia Major in Bahrain
por: Garadah, Taysir S., et al.
Publicado: (2013)

Risk Stratification and in Hospital Morality in Patients Presenting with Acute Coronary Syndrome (ACS) in Bahrain
por: Garadah, Taysir S, et al.
Publicado: (2018)

Hematological and hemorheological Determinants of the Six-Minute Walk Test Performance in Children with Sickle Cell Anemia
por: Waltz, Xavier, et al.
Publicado: (2013)

Physical activity level and performance in the six-minute walk test of children and adolescents with sickle cell anemia
por: Melo, Hugo Nivaldo, et al.
Publicado: (2017)

Hydroxyurea and sickle cell anemia: effect on quality of life
por: Ballas, Samir K, et al.
Publicado: (2006)

The influence of hydroxyurea on oxidative stress in sickle cell anemia
por: Torres, Lidiane de Souza, et al.
Publicado: (2012)

QTc Interval and QT Dispersion in Patients with Thalassemia Major: Electrocardiographic (EKG) and Echocardiographic Evaluation
por: Garadah, Taysir S., et al.
Publicado: (2010)

Comment on "The influence of hydroxyurea on oxidative stress in sickle cell anemia"
por: van Beers, Eduard Johannes, et al.
Publicado: (2012)

Hydroxyurea: Clinical and Hematological Effects in Patients With Sickle Cell Anemia
por: Keikhaei, Bijan, et al.
Publicado: (2016)

Hydroxyurea treatment for adult sickle cell anemia patients in Kinshasa
por: Kabuyi, Paul Lumbala, et al.
Publicado: (2023)

Outcome of Undergraduate Medical Education using Medical Simulation according to Students’ Feedback
por: Riaz, Salman, et al.
Publicado: (2020)

Genetic and biochemical markers of hydroxyurea therapeutic response in sickle cell anemia
por: Silva, Danilo Grunig Humberto, et al.
Publicado: (2013)

Menopause in Brazilian women with sickle cell anemia with and without hydroxyurea therapy
por: Queiroz, Ana Mach, et al.
Publicado: (2021)

Intensive hydroxyurea dosing in very young children with sickle cell anemia
por: Wang, Winfred C., et al.
Publicado: (2023)

The burden and quality of life of caregivers of sickle cell anemia patients taking hydroxyurea versus those not taking hydroxyurea
por: da Silva, Luiz Bernardino Lima, et al.
Publicado: (2012)

The pro-BNP Serum Level and Echocardiographic Tissue Doppler Abnormalities in Patients with Beta Thalassemia Major
por: Garadah, Taysir S., et al.
Publicado: (2010)

Predictors of Abnormal Bone Mass Density in Adult Patients with Homozygous Sickle-Cell Disease
por: Garadah, Taysir S, et al.
Publicado: (2015)

Pulsed and Tissue Doppler Echocardiographic Changes in Hypertensive Crisis with and without End Organ Damage
por: Garadah, Taysir, et al.
Publicado: (2011)

Comment on "The burden and quality of life of caregivers of sickle cell anemia patients taking hydroxyurea versus those not taking hydroxyurea"
por: Souza, José Carlos, et al.
Publicado: (2012)

Six minute walking distance in kyphoscoliosis patients with chronic respiratory failure
por: Karakurt, Zuhal, et al.
Publicado: (2010)

Lung function and six-minute walk test performance in individuals with sickle cell disease
por: Ohara, Daniela G., et al.
Publicado: (2014)

Impaired Economy of Gait and Decreased Six-Minute Walk Distance in Parkinson's Disease
por: Katzel, Leslie I., et al.
Publicado: (2012)

Overweight-mortality paradox and impact of six-minute walk distance in lung transplantation
por: Chaikriangkrai, Kongkiat, et al.
Publicado: (2015)

Side effects of hydroxyurea in patients with Thalassemia major and thalassemia intermedia and sickle cell anemia
por: Ghasemi, A, et al.
Publicado: (2014)

From Infancy to Adolescence: Fifteen Years of Continuous Treatment With Hydroxyurea in Sickle Cell Anemia
por: Hankins, Jane S., et al.
Publicado: (2014)

Sickle-cell Anemia and Latent Diastolic Dysfunction: Echocardiographic Alterations
por: Fattori, André, et al.
Publicado: (2015)

Reference equations for the six-minute walk distance based on a Brazilian multicenter study
por: Britto, Raquel R., et al.
Publicado: (2013)

Characteristics and determinants of endurance cycle ergometry and six-minute walk distance in patients with COPD
por: Andrianopoulos, Vasileios, et al.
Publicado: (2014)

Six-minute walk distance and survival time in patients with idiopathic pulmonary fibrosis in Brazil
por: Mancuzo, Eliane Viana, et al.
Publicado: (2018)

Usefulness of the desaturation–distance ratio from the six-minute walk test for patients with COPD
por: Fujimoto, Yukari, et al.
Publicado: (2017)

Six-minute walking distance in healthy Chinese people older than 60 years
por: Zou, He, et al.
Publicado: (2020)

Determinants of Six-Minute Walk Distance in Idiopathic Pulmonary Fibrosis and Idiopathic Pleuroparenchymal Fibroelastosis
por: Sato, Naofumi, et al.
Publicado: (2022)

The correlation between six-minute walking distance and maximum phonation time in healthy adults
por: Santausa, Febrian Mulya, et al.
Publicado: (2023)

Hydroxyurea Treatment for Sickle Cell Disease
por: Steinberg, Martin H.
Publicado: (2002)

Determinants of distance walked during the six-minute walk test in patients undergoing cardiac surgery at hospital discharge
por: Oliveira, Géssica Uruga, et al.
Publicado: (2014)

Hydroxyurea treatment is associated with reduced degree of oxidative perturbation in children and adolescents with sickle cell anemia
por: Vinhaes, Caian L., et al.
Publicado: (2020)

Longitudinal analysis of cardiac abnormalities in pediatric patients with sickle cell anemia and effect of hydroxyurea therapy
por: Dhar, Arushi, et al.
Publicado: (2021)

Reference Value for the Distance Walked in the Six-Minute Walk Test in Obese Brazilian Men in the Preoperative Period of Bariatric Surgery
por: Luchesa, Cesar Antonio, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_na82tlup4pu6e1bmmfbidnek0t